Concepedia

Paul Ramage

PR

Statistics

Publications

36

Citations

2.8K

H-Index

26

Active since

1980

Affiliations

Novartis (Switzerland)(Current)

Novartis Institutes for BioMedical Research

Novartis (United States)

University of Edinburgh

Scripps Research Institute

Paul Ramage is an author at Novartis (Switzerland) specializing in life sciences, biochemistry, and pharmacology.

Publications per year

1980–2023

36

Publications

36

COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

Lennard Y. W. Lee, Jean‐Baptiste Cazier, Thomas Starkey et al. · The Lancet Oncology · 2020 · 600 citations · Full text

Medicine, Oncology, Cancer Epidemiology +16

Structural basis for LFA-1 inhibition upon lovastatin binding to the CD11a I-domain 1 1Edited by F. E. Cohen

Joerg Kallen, Karl Welzenbach, Paul Ramage et al. · Journal of Molecular Biology · 1999 · 256 citations

Life Sciences, Immunology, Pharmacology +10

Structural Basis for the Exceptional in vivo Efficacy of Bisphosphonate Drugs

Jean‐Michel Rondeau, Francis Bitsch, E. Bourgier et al. · ChemMedChem · 2006 · 223 citations

Life Sciences, Biochemistry, Pharmacology +17

NMR solution structure of the pathogenesis-related protein P14a

César Fernández Fernández, Thomas Szyperski, Thierry Bruyère et al. · Journal of Molecular Biology · 1997 · 155 citations

Life Sciences, Biochemistry, Molecular Biology +9

MAA868, a novel FXI antibody with a unique binding mode, shows durable effects on markers of anticoagulation in humans

Alexander W. Koch, Nikolaus Schiering, Samu Melkko et al. · Blood · 2019 · 122 citations · Full text

Pharmacy, Hematology, Pharmacology +16

1–5 of 36